Suzhou Industrial Park

Home page > category report > Industries & Enterprises

Entrepreneur decodes small molecule drugs at SIP-STIO’s information session

Date:   |   Source:       Font Size:    A   A   A
Dr. Lyu Jiasheng, founder and general manager of Risen, an SIP-based company engaged in developing small molecule drugs used in treatments of degenerative and tumor diseases, gave a talk on “Development of Innovative Small Molecule Drugs” at the recent information session held by SIP Science and Technology and Information Office (SIP-STIO).
The event was part of SIP-STIO’s long-term program initiated in 2016 to invite professionals from research institutes, enterprises and investment organizations to share their expertise and experience with related local administrative staff on a weekly basis.
At the event, Lyu gave the participants a specific introduction to Risen’s development course, R&D team and candidate drugs in development and clinical trials.

August 12, 2019